Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anterix Inc. Director's Dealing 2024

Mar 2, 2024

33018_dirs_2024-03-01_fd39b6ed-af58-44cd-97be-979a5c8d3f17.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Anterix Inc. (ATEX)
CIK: 0001304492
Period of Report: 2024-02-28

Reporting Person: Gerbrandt Ryan (Chief Operating Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-02-28 Stock Option (Right to Buy) $37.42 A 60000 Acquired 2034-02-28 Common Stock (60000) Direct

Footnotes

F1: 8,000 of the option shares vest and become exercisable on May 22, 2024; 32,000 additional option shares vest and become exercisable on May 22, 2025; and the remaining 20,000 unvested option shares vest and become exercisable on May 22, 2026.